Literature DB >> 2387290

Effects of a restrictive antibiotic policy on clinical efficacy of antibiotics and susceptibility patterns of organisms.

A W Sturm1.   

Abstract

To assess the impact of a restrictive antimicrobial policy, the efficacy of therapeutic and prophylactic antibiotic regimens and the susceptibility patterns of infecting bacterial microorganisms were studied during a two-month period in 1986 in inpatients in a general hospital. Twenty-eight percent of patients received antimicrobial agents, 21% as treatment and 7% as prophylaxis. In the 359 evaluable episodes of infection cure was obtained in 88% of cases with the initial therapy and in 7% after a change of drugs, but treatment failed in 5%. Of the 18 cases of failure, improvement was seen in eight although the infection persisted. Ten patients died but in seven of them the infection only partially contributed to this outcome. Ten (8%) of 127 patients receiving antimicrobial prophylaxis developed an infection but in three there was no relation to the condition for which the prophylactic regimen was originally prescribed. No changes were found in the susceptibility patterns of microorganisms.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2387290     DOI: 10.1007/bf01979466

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  22 in total

1.  An inocula replicating apparatus for routine testing of bacterial susceptibility to antibiotics.

Authors:  E STEERS; E L FOLTZ; B S GRAVES
Journal:  Antibiot Chemother (Northfield)       Date:  1959-05

2.  A seven year survey of antibiotic susceptibility and its relationship with usage.

Authors:  R J Courcol; M Pinkas; G R Martin
Journal:  J Antimicrob Chemother       Date:  1989-03       Impact factor: 5.790

3.  Rational use of antimicrobial agents and diagnostic microbiology facilities.

Authors:  A W Sturm
Journal:  J Antimicrob Chemother       Date:  1988-08       Impact factor: 5.790

4.  Survey of antibiotic prescribing in a district general hospital. I. Pattern of use.

Authors:  F Moss; M W McNicol; D A McSwiggan; D L Miller
Journal:  Lancet       Date:  1981-08-15       Impact factor: 79.321

5.  Transposons and trimethoprim resistance.

Authors:  H Richards; N Datta
Journal:  Br Med J (Clin Res Ed)       Date:  1981-04-04

6.  Novel resistance selected by the new expanded-spectrum cephalosporins: a concern.

Authors:  C C Sanders
Journal:  J Infect Dis       Date:  1983-03       Impact factor: 5.226

7.  Evaluation of imipenem/cilastatin for treatment of infection in an elderly population.

Authors:  M D Smith; C Bielawska; M C Kelsey; G Rai; N B Deaney
Journal:  J Antimicrob Chemother       Date:  1988-04       Impact factor: 5.790

8.  A prospective randomized trial of ceftazidime versus cefazolin/tobramycin in the treatment of hospitalized patients with pneumonia.

Authors:  L A Mandell; L E Nicolle; A R Ronald; S J Landis; R Duperval; G K Harding; H G Robson; R Feld; J Vincelette; I Fong
Journal:  J Antimicrob Chemother       Date:  1987-07       Impact factor: 5.790

9.  Comparative, double-blind study of oral ciprofloxacin and intravenous cefotaxime in skin and skin structure infections.

Authors:  C H Ramirez-Ronda; S Saavedra; C R Rivera-Vázquez
Journal:  Am J Med       Date:  1987-04-27       Impact factor: 4.965

10.  Pefloxacin in the treatment of nosocomial lower respiratory tract infections in intensive care patients.

Authors:  C Martin; F Gouin; F Fourrier; W Junginger; B L Prieur
Journal:  J Antimicrob Chemother       Date:  1988-06       Impact factor: 5.790

View more
  5 in total

Review 1.  Pharmacoeconomics of antibacterial treatment.

Authors:  P G Davey; M M Malek; S E Parker
Journal:  Pharmacoeconomics       Date:  1992-06       Impact factor: 4.981

2.  Coagulase-negative staphylococcal skin carriage among neonatal intensive care unit personnel: from population to infection.

Authors:  Vishal Hira; Marcel Sluijter; Wil H F Goessens; Alewijn Ott; Ronald de Groot; Peter W M Hermans; René F Kornelisse
Journal:  J Clin Microbiol       Date:  2010-09-08       Impact factor: 5.948

Review 3.  Once-daily aminoglycoside administration in gram-negative sepsis. Economic and practical aspects.

Authors:  S E Parker; P G Davey
Journal:  Pharmacoeconomics       Date:  1995-05       Impact factor: 4.981

4.  Impact of a multidisciplinary approach on antibiotic consumption, cost and microbial resistance in a Czech hospital.

Authors:  Rene Mach; Jiri Vlcek; Miroslava Prusova; Petr Batka; Vladan Rysavy; Ales Kubena
Journal:  Pharm World Sci       Date:  2007-07-04

5.  Antibiotic prescription and cost patterns in a general intensive care unit.

Authors:  Norberto Krivoy; Wissam Abed El-Ahal; Yaron Bar-Lavie; Salim Haddad
Journal:  Pharm Pract (Granada)       Date:  2007
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.